Viewing Study NCT06458595


Ignite Creation Date: 2025-12-24 @ 1:48 PM
Ignite Modification Date: 2025-12-30 @ 9:49 PM
Study NCT ID: NCT06458595
Status: RECRUITING
Last Update Posted: 2024-11-29
First Post: 2024-06-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of KH658 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Sponsor: Chengdu Origen Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module